Novadaq Technologies Inc. (TSE:NDQ)‘s stock had its “outperform” rating restated by research analysts at Wedbush in a research report issued on Thursday. They presently have a C$17.00 price target on the stock.
Separately, Royal Bank Of Canada reiterated an “outperform” rating on shares of Novadaq Technologies in a research note on Thursday, July 7th.
Shares of Novadaq Technologies (TSE:NDQ) opened at 14.92 on Thursday. The stock’s 50 day moving average is $15.46 and its 200-day moving average is $13.98. The firm’s market capitalization is $856.93 million. Novadaq Technologies has a 52-week low of $10.81 and a 52-week high of $20.40.
Novadaq Technologies Company Profile
Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.